March 26, 2018 / 11:47 AM / 9 months ago

BRIEF-Kala Pharmaceuticals Posts Q4 Loss Per Share $0.46

March 26 (Reuters) - Kala Pharmaceuticals Inc:

* KALA PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS

* Q4 LOSS PER SHARE $0.46

* Q4 EARNINGS PER SHARE VIEW $-0.37 — THOMSON REUTERS I/B/E/S

* ENDED 2017 WITH $114.6 MILLION IN CASH

* PDUFA TARGET ACTION DATE FOR INVELTYS IS AUGUST 24, 2018 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below